---
title: "Tellgen's subsidiary Jiangxi Tellgen has obtained two medical device registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251808332.md"
description: "Tellgen's wholly-owned subsidiary Jiangxi Tellgen recently obtained two medical device registration certificates issued by the Jiangxi Provincial Drug Administration. These two products are the anti-histidyl tRNA synthetase antibody IgG test kit and the anti-transcription intermediary factor 1-γ antibody IgG test kit, mainly used for the auxiliary diagnosis of polymyositis/dermatomyositis"
datetime: "2025-08-06T10:26:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251808332.md)
  - [en](https://longbridge.com/en/news/251808332.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251808332.md)
generator: "portal-rs"
---

# Tellgen's subsidiary Jiangxi Tellgen has obtained two medical device registration certificates

According to the Zhitong Finance APP, Tellgen (300642.SZ) announced that its wholly-owned subsidiary Jiangxi Tellgen Life Science Technology Co., Ltd. ("Jiangxi Tellgen") recently obtained two medical device registration certificates issued by the Jiangxi Provincial Drug Administration, including: Anti-histidyl tRNA synthetase antibody IgG detection kit (flow fluorescence luminescence method) and Anti-transcription intermediary factor 1-γ antibody IgG detection kit (flow fluorescence luminescence method). The two certified products are mainly suitable for the auxiliary diagnosis of polymyositis/dermatomyositis (PM/DM)

### Related Stocks

- [300642.CN](https://longbridge.com/en/quote/300642.CN.md)

## Related News & Research

- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [17:15 ETHost Defense® Launches New Functional Mushroom Supplement for Pets](https://longbridge.com/en/news/296402242.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [04:20 ETSphingoTec to Engage with Clinical and Industry Partners at Major 2026 Conferences](https://longbridge.com/en/news/296322953.md)
- [Dicot Pharma says three LIB-01 erectile dysfunction trial abstracts win oral slots at SMSNA meeting](https://longbridge.com/en/news/296312317.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**